Table 55Strength of evidence for studies: TACE compared with TEA

OutcomeNo of Studies

Type of Study
Risk of BiasConsistencyDirectnessPrecisionOverall Grade
Overall Survival1; Yu et al. 200963
Retrospective case control
HighUnknownDirectPreciseInsufficient
Quality of Life0UnknownUnknownUnknownUnknownInsufficient
Time to Progression1; Yu et al. 200963
Retrospective case control
HighUnknownIndirectPreciseInsufficient
Local Control0UnknownUnknownUnknownUnknownInsufficient
Length of Stay0UnknownUnknownUnknownUnknownInsufficient
Days of Work Missed0UnknownUnknownUnknownUnknownInsufficient
Adverse Events0UnknownUnknownUnknownUnknownInsufficient

From: Results

Cover of Local Therapies for Unresectable Primary Hepatocellular Carcinoma
Local Therapies for Unresectable Primary Hepatocellular Carcinoma [Internet].
Comparative Effectiveness Reviews, No. 114.
Belinson S, Yang Y, Chopra R, et al.

PubMed Health. A service of the National Library of Medicine, National Institutes of Health.